Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247
- PMID: 16720978
Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247
Erratum in
- Hum Antibodies. 2006;15(3):113
Abstract
By immunizing mice sequentially with six different V3 peptides we obtained a murine monoclonal antibody (MAb) C25, and its humanized counterpart KD-247. The MAb recognizes the sequence IGPGRA at the tip of the V3 loop and displays broad neutralizing activity against a variety of HIV-1 isolates. KD-247 was tested in an ex vivo neutralization assay to determine its capability to contain the spread of a quasi species population of clade B HIV-1 derived from two patients. The epitope of KD-247 was generally matching with the V3 sequences of various clones isolated from plasma and peripheral blood mononuclear cells (PBMC) of two patients. Complete or strong inhibition of viral replication was observed when the patients' PBMC were cultured with a high concentration of KD-247. Some neutralization escape variants, which had mutations in the V3 or outside of the V3 loop, emerged only at a low concentration of the MAb. These results suggest that KD-247 could be a good candidate for immunotherapy against HIV-1 in vivo.
Similar articles
-
Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.J Virol. 2007 Apr;81(8):3757-68. doi: 10.1128/JVI.01544-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251298 Free PMC article.
-
Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.Dev Biol Stand. 1990;72:315-41. Dev Biol Stand. 1990. PMID: 2282990
-
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588. Biochem J. 2006. PMID: 16827663 Free PMC article.
-
Structural studies of human HIV-1 V3 antibodies.Hum Antibodies. 2005;14(3-4):73-80. Hum Antibodies. 2005. PMID: 16720977 Review.
-
Improving on nature: focusing the immune response on the V3 loop.Hum Antibodies. 2005;14(3-4):69-72. Hum Antibodies. 2005. PMID: 16720976 Review.
Cited by
-
Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.Curr HIV Res. 2018;16(5):374-382. doi: 10.2174/1570162X17666190204101154. Curr HIV Res. 2018. PMID: 30714528 Free PMC article.
-
Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.Cell Mol Biol (Noisy-le-grand). 2012 Dec 22;58(1):71-9. Cell Mol Biol (Noisy-le-grand). 2012. PMID: 23273194 Free PMC article.
-
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models.Front Immunol. 2022 Feb 22;13:828319. doi: 10.3389/fimmu.2022.828319. eCollection 2022. Front Immunol. 2022. PMID: 35273608 Free PMC article.
-
Antiviral drugs specific for coronaviruses in preclinical development.Curr Opin Virol. 2014 Oct;8:45-53. doi: 10.1016/j.coviro.2014.06.002. Epub 2014 Jul 2. Curr Opin Virol. 2014. PMID: 24997250 Free PMC article. Review.
-
Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.FASEB J. 2015 Jan;29(1):70-80. doi: 10.1096/fj.14-252262. Epub 2014 Oct 28. FASEB J. 2015. PMID: 25351987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical